Skip to main content
. 2017 Nov 3;15(1):221–228. doi: 10.3892/ol.2017.7340

Figure 3.

Figure 3.

Kaplan-Meier survival curves for 209 patients with Stage II colorectal cancer. Disease-free survival curves stratified by (A) preoperative serum Sialyl Lewisx (SLX) level, (B) SLX expression at the invasive front, and (C) SLX expression at the non-invasive frontal regions. Cancer specific survival curves stratified by (D) preoperative serum SLX level, (E) SLX expression at the invasive front, and (F) SLX expression at the non-invasive frontal regions.